US2019275024A1PendingUtilityA1
Piperidinone carboxamide azaindane cgrp receptor antagonists
Est. expiryNov 12, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Ian M. BellMark E. FraleySteven N. GallicchioAnthony GinnettiHelen J. MitchellDaniel V. PaoneDonnette D. StaasCheng WangC. Blair Zartman
A61P 43/00A61P 9/00A61P 3/10A61P 9/08A61P 25/08A61P 25/04A61P 3/04A61P 29/00A61P 31/04A61P 25/36A61P 25/06A61P 17/04A61P 1/04A61P 13/10A61P 11/06A61P 19/02A61P 17/06A61K 31/4545A61K 31/435A61K 31/438C07D 471/20C07D 471/10A61K 31/437
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Claims
exact text as granted — not AI-modified1 - 35 . (canceled)
36 . A compound selected from the following group:
or a salt or stereoisomer thereof.
37 . The compound according to claim 36 , wherein the compound is:
or a salt or stereoisomer thereof.
38 . The compound according to claim 36 , wherein the compound is:
or a salt or stereoisomer thereof.
39 . The compound according to claim 36 , wherein the compound is:
or a salt or stereoisomer thereof.
40 . A compound selected from the following group:
or a salt or stereoisomer thereof.
41 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
42 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
43 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
44 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
45 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
46 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
47 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
48 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
49 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
50 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
51 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
52 . The compound according to claim 40 , wherein the compound is:
or a salt or stereoisomer thereof.
53 . A compound selected from the following group:
or a salt or stereoisomer thereof.
54 . The compound according to claim 53 , wherein the compound is:
or a salt or stereoisomer thereof.
55 . The compound according to claim 53 , wherein the compound is:
or a salt or stereoisomer thereof.Join the waitlist — get patent alerts
Track US2019275024A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.